Unsuspected Skeletal Sarcoidosis Mimicking Metastatic Disease on FDG Positron Emission Tomography and Bone Scintigraphy

Clinical Nuclear Medicine

Volumn 28, Issue 3, 2003, Pages 176-179

  Ludwig, Vinicius ^a   Fordice, Sarina ^b   Lamar, Ruth ^a   Martin, William H ^a   Delbeke, Dominique ^a,b  

^a Pulmonary Disease Program   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone Scintigraphy; Fluorodeoxyglucose; Positron Emission Tomography; Skeletal Sarcoidosis

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BONE DISEASE; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EYE; FEMALE; FEMUR; GRANULOMATOSIS; HUMAN; KIDNEY; LIVER; LOW BACK PAIN; LUNG; MEDIASTINUM; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; SKELETON; SKIN; SPLEEN; BONE TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; INCIDENTAL FINDING; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; WHOLE BODY COUNTING;

BONE DISEASES; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, EMISSION-COMPUTED; WHOLE-BODY COUNTING;

EID: 85047693863     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RLU.0000053528.35645.70     Document Type: Article

References (17)

1. James DG: Sarcoidosis. Post Med J 77:177, 2001.
2. Sundaram M, Place H, Shaffer W, et al: Progressive destructive vertebral sarcoid leading to surgical fusion. Skeletal Radiol 28:717, 1999.
3. Poyanli A, Poyanli O, Sencer S, et al: Vertebral sarcoidosis: imaging findings. Eur Radiol 10:92, 2000.
4. Mana J, Gomez-Vaquero C, Dorca J, et al: Vertebral and rib sarcoidosis: long term clinical remission with methotrexate. Clin Rheumatol 18:492, 1999.
5. Zhuang H, Alavi A: 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32:47, 2002.
6. Shreve P, Anzai Y, Wahl R: Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19:61, 1999.
7. Gambhir SS, Czernin J, Schwimmer J, et al: A tabulated summary of the FDG PET literature. J Nucl Med 42 (Suppl):1S, 2001.
8. Lewis P, Salama A: Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35:1647, 1994.
9. Aoki J, Watanabe H, Shinozaki T, et al: FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 219:774, 2001.
10. Kole A, Nieweg O, Hoekstra H, et al: Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med 39:810, 1998.
11. Kobayashi A, Shinozaki T, Shinjyo Y, et al: FDG PET in the evaluation of sarcoidosis with bone lesion. Ann Nucl Med 14:311, 2000.
12. Vanhagen PM, Krenning EP, Reubi JC, et al: Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 21:497, 1994.
13. Lebtahi R, Crestani B, Belmatoug N, et al: Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med 42:21, 2001.
14. Kwekkeboom DJ, Krenning EP, Khogs, et al: Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 25:1284, 1998.
15. Brudin LH, Valind SO, Rhodes CG, et al: Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 21:297, 1994.
16. Alavi A, Buchpiguel C, Loessner A: Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J Nucl Med 35:1650, 1994.
17. Yamada Y, Uchida Y, Tatsumi K, et al: Fluorine-18-fluorodwoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 39:1160, 1998.